AMAYA COLBERT: Open Payments
NPI 1689425324 · KENNER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 14 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $66 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $213 |
| AstraZeneca Pharmaceuticals LP | 2 | $139 |
| Organon LLC | 2 | $38 |
| Lilly USA, LLC | 2 | $35 |
| Exact Sciences Corporation | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: Descovy, BREZTRI, NEXPLANON, MOUNJARO, The Cologuard Plus Collection Kit, FARXIGA, NEXLETOL, Yeztugo.
Industry payments across LA — which companies pay providers there.
